Blood thinners prevent infection with coronavirus

Researchers Marta Bermejo-Jambrina and Julia Eder, under supervision of Theo Geijtenbeek, discovered that heparan sulphates are involved in infection with the coronavirus.

First data: COVID-19 vaccine effectiveness in patients with blood diseases

The safety and protection offered by various vaccines against COVID-19 is clear-cut in healthy individuals. But how well do SARS-Cov-2 vaccines protect people with a weakened immune response?

Large grant to investigate monoclonal antibody therapy against COVID-19

To study monoclonal antibody therapy against COVID-19 Joost Wiersinga and Godelieve de Bree will receive a 1.3 million euro grant by NWO and ZonMw.

Global genetics consortium uncovers COVID-19 risk factors

An international collaboration, including researchers from Amsterdam UMC, has identified several host-specific genetic factors associated with SARS-CoV-2 infection and COVID-19 severity.

Strength in numbers through COVID-19

Internist and infectious disease specialist Joost Wiersinga wrote a review of all the scientific medical literature published on COVID-19. The July 2020 JAMA article was an immediate resounding success.

The image of vaccines: why taking a vaccine when it appears to be unsafe?

In the last months, APH researcher Danielle Timmermans shed her light on the communication of the vaccine strategy from the Dutch government.

COVID-19 Biobank

The COVID-19 Biobank is set up with the aim to enable as much research as possible in patients with COVID-19. The biobank collects a.o. clinical data, DNA and blood samples from COVID-19 patients hospitalized in Amsterdam UMC.

COVID-19 Task Force Research

To enhance internal coordination between all COVID-19 research activities, Amsterdam UMC have set up five COVID-19 expert groups, which report to the overarching COVID-19 Task Force Research.